Corrigendum to "Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation": [Annals of Oncology 28 (2017):2503-2510]
Ann Oncol. 2023 Mar;34(3):322.
doi: 10.1016/j.annonc.2022.08.004.
Epub 2022 Sep 6.
1 Hematology/Respiratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan. Electronic address: takamaz@staff.kanazawa-u.ac.jp.
2 Department of Hematology, National Hospital Organization Disaster Medical Center of Japan, Tachikawa, Japan.
3 Adaptive Biotechnologies Corp., South San Francisco, USA.
4 Division of Internal Medicine, Keiju Kanazawa Hospital, Kanazawa, Japan.
5 Department of Medical Oncology, Iwate Medical University School of Medicine, Morioka, Japan.
6 Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
7 Department of Hematology/Oncology, Tokai University Hachioji Hospital, Hachioji, Japan.
8 Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa, Japan.
9 Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, Sapporo, Japan.
10 Department of Hematology, Toyama Red Cross Hospital, Toyama, Japan.
11 Department of Hematology, Kinki University School of Medicine Nara Hospital, Ikoma, Nara, Japan.
12 Division of Internal Medicine, Toyama City Hospital, Toyama, Japan.
13 Hematology/Respiratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
14 Department of Hematology, National Hospital Organization Shibukawa Medical Center, Shibukawa, Japan.
15 Department of Hematology, Shizuoka City Shimizu Hospital, Shizuoka, Japan.